Insider · CIK 0001191504
Kurt J Hilzinger
Files at HUM (HUMANA INC), OTLK (Outlook Therapeutics, Inc.). First filing May 27, 2026, latest May 27, 2026.
In brief
Kurt J Hilzinger files SEC Form 4 as director at OTLK (Outlook Therapeutics, Inc.), and also at HUM (HUMANA INC). Since May 27, 2026, Kurt J Hilzinger has reported 1 open-market buy worth $177k and 0 open-market sells worth $0, the latest filed on May 27, 2026.
A track record needs three past buys with six months of prices behind them; Kurt J Hilzinger has 0, so none is measured yet.
The newest scored trade: bought $177k of OTLK on May 26, 2026, filed May 27, 2026, scored 52 (moderate). In the last 12 months: 1 buy worth $177k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OTLK: Outlook Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | Outlook Therapeutics, Inc. | $177k 400,000 shares | +1691% | - |
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +238 | $384.91 | $92k | 16,772 | 12 d ago |
| Jun 30, 2026 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +233 | $392.32 | $91k | 16,534 | Jul 2, 2026 |
| May 26, 2026 | OTLK Outlook Therapeutics, Inc. | POpen-market purchase Common Stock | +400,000 | $0.44 | $177k | 423,655 | May 27, 2026 |
| Mar 31, 2026 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +536 | $170.66 | $91k | 16,301 | Apr 2, 2026 |
| Jan 2, 2026 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +766 | $0.00 | $0 | 24,800 | Jan 5, 2026 |
| Dec 31, 2025 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +611 | $258.87 | $158k | 3,364 | Jan 5, 2026 |
| Dec 31, 2025 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +357 | $258.87 | $92k | 15,765 | Jan 5, 2026 |
| Oct 1, 2025 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +286,734 | $0.00 | $0 | 286,734 | Oct 3, 2025 |
| Oct 3, 2025 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +90,638 | $0.00 | $0 | 90,638 | Oct 3, 2025 |
| Sep 30, 2025 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +364 | $257.79 | $94k | 15,408 | Oct 2, 2025 |
| Jun 30, 2025 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +399 | $242.82 | $97k | 15,044 | Jul 2, 2025 |
| Mar 31, 2025 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +345 | $263.88 | $91k | 14,645 | Apr 2, 2025 |
| Jan 2, 2025 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +783 | $0.00 | $0 | 24,034 | Jan 3, 2025 |
| Dec 31, 2024 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +565 | $254.93 | $144k | 2,753 | Jan 3, 2025 |
| Dec 31, 2024 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +673 | $254.93 | $172k | 14,300 | Jan 3, 2025 |
| Mar 7, 2024 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +94,441 | $0.00 | $0 | 94,441 | Mar 8, 2024 |
| Dec 31, 2023 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +304 | $456.91 | $139k | 2,188 | Jan 3, 2024 |
| Dec 31, 2023 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +211 | $456.91 | $96k | 12,816 | Jan 3, 2024 |
| Jan 2, 2024 | HUM HUMANA INC | AGrant or award Restricted Stock Unitsderivative | +430 | $0.00 | $0 | 430 | Jan 3, 2024 |
Questions about Kurt J Hilzinger
Answered from the filings on this page, as of the latest one.
Is Kurt J Hilzinger buying or selling?
In the last 12 months Kurt J Hilzinger reported 1 open-market buy worth $177k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $177k of OTLK on May 26, 2026. Grants, option exercises and tax withholding are not counted.
How did Kurt J Hilzinger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kurt J Hilzinger has 0.
Where does Kurt J Hilzinger file Form 4?
Kurt J Hilzinger has filed Form 4 at OTLK (Outlook Therapeutics, Inc.); HUM (HUMANA INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.